This study presents the result of an SMA NBS program for five consecutive years in Taiwan, which included 22 SMN1 homozygous deletion cases and one case with SMN1 compound heterozygosity from 446,966 newborns. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.